How to reach Hispanics with healthcare messages? Mine the data first, Klick saysnews2022-04-29T07:37:46+00:00April 29th, 2022|Fierce Pharma|
The Top Line podcast: Pharma advertising shifts gears and Novartis taps a surprising M&A czar, plus this week’s headlinesnews2022-04-29T00:30:55+00:00April 29th, 2022|Fierce Pharma|
CMI Media Group launches new practice to help pharma reach out to diverse audiencesnews2022-04-28T22:15:51+00:00April 28th, 2022|Fierce Pharma|
BeiGene CEO touts ‘strategic asset’ in flagship US site and a fix to stock delisting risknews2022-04-28T15:17:04+00:00April 28th, 2022|Fierce Pharma|
If Lilly’s Alzheimer’s prospect proves its merit, it’s ‘inconceivable’ CMS wouldn’t cover the med: execnews2022-04-28T15:13:24+00:00April 28th, 2022|Fierce Pharma|
Sanofi’s Dupixent puts on another stellar show, and it’s still ‘at the beginning’ of its journey: execnews2022-04-28T14:46:53+00:00April 28th, 2022|Fierce Pharma|
Despite early doubts, Merck’s COVID antiviral beats sales expectations and drives big growthnews2022-04-28T14:44:49+00:00April 28th, 2022|Fierce Pharma|
WuXi Advanced Therapies teams with Singapore group on cell therapy production technews2022-04-28T13:14:07+00:00April 28th, 2022|Fierce Pharma|
BioMarin posts record quarterly sales as Voxzogo launch heats upnews2022-04-28T12:38:42+00:00April 28th, 2022|Fierce Pharma|
Moderna to name Montreal for new biomanufacturing facility: reportnews2022-04-28T12:17:57+00:00April 28th, 2022|Fierce Pharma|
